Oriental Aromatics Limited (OAL) has announced a significant change in its senior management. Ms. Savita Dalvi, who held the position of Vice President - Sales & Marketing, has resigned from her role, citing personal reasons.

Resignation Details

The company disclosed this information in a regulatory filing to the BSE and NSE on November 18, 2025. According to the filing, Ms. Dalvi tendered her resignation via email on October 18, 2025. The company has accepted her resignation, and she has been relieved of her duties effective from the close of business hours on November 18, 2025.

Corporate Disclosure

In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Oriental Aromatics provided the following details:

Impact on Senior Management

Ms. Dalvi was categorized as Senior Management Personnel (SMP) within the company. Her departure marks a change in the leadership structure of Oriental Aromatics' sales and marketing division.

Company Response

The company has acknowledged Ms. Dalvi's contribution and has complied with all necessary regulatory requirements regarding the disclosure of this change in senior management. Oriental Aromatics has made the information available on its official website, ensuring transparency with its stakeholders.

The resignation of a key executive like the VP of Sales & Marketing could potentially impact the company's strategic direction in these areas. However, Oriental Aromatics has not provided any information about a successor or interim arrangements for the role at this time.

Investors and stakeholders of Oriental Aromatics Limited may want to keep an eye on further announcements from the company regarding any potential restructuring or new appointments in the sales and marketing department.

Oriental Aromatics Limited , a key player in the fine chemicals sector, has released its financial results for the second quarter, revealing a mixed performance with revenue growth but a significant decline in profitability.

Revenue Growth

The company reported a consolidated revenue of 2.70 billion rupees for Q2, marking an increase from 2.40 billion rupees in the same quarter of the previous year. This 12.5% year-over-year growth in revenue indicates a robust demand for the company's products.

Profitability Challenges

Despite the revenue growth, Oriental Aromatics faced substantial challenges in maintaining its profitability:

• Net Profit: The consolidated net profit saw a sharp decline, falling to 7.00 million rupees from 148.00 million rupees year-over-year, representing a 95.3% decrease.
• EBITDA: Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) dropped to 173.00 million rupees from 286.00 million rupees in the corresponding quarter last year.
• EBITDA Margin: The EBITDA margin compressed significantly to 6.36% from 12.09% in the previous year's quarter.

Financial Position

The company's financial position as of September 30 shows:

Cash Flow and Operations

Oriental Aromatics reported negative cash flow from operating activities, with a net outflow of 30.42 crore rupees for the half-year ended September 30. This contrasts with a positive cash flow of 14.71 crore rupees in the same period last year, indicating potential working capital challenges.

Segment Performance

The company continues to operate in a single reportable segment, 'Fine Chemicals', as per the requirements of IND AS 108.

Subsidiary Performance

The company's wholly-owned subsidiary, Oriental Aromatics & Sons Limited, which commenced commercial production on November 12, 2024, at its greenfield manufacturing facility in Mahad, Maharashtra, has contributed to the consolidated results. The subsidiary reported losses (net of deferred tax credit) of 6.02 crore rupees for the quarter ended September 30.

Investors and stakeholders may be watching closely to see how Oriental Aromatics addresses the profitability challenges while maintaining its revenue growth in the coming quarters. The company's ability to improve its EBITDA margin and bottom line could be crucial for its financial health and market performance.